Potential Risks and Benefits of Multiple Sclerosis Immune Therapies in the COVID-19 Era: Clinical and Immunological Perspectives

Coronavirus SARS-CoV2 has emerged as one of the greatest infectious disease health challenges in a century. Patients with multiple sclerosis (MS) have a particular vulnerability to infections through their use of immunosuppressive disease-modifying therapies (DMTs). Specific DMTs pose particular ris...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhise, Vikram, Dhib-Jalbut, Suhayl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Current Perspectives
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7853164/
https://www.ncbi.nlm.nih.gov/pubmed/33533012
http://dx.doi.org/10.1007/s13311-021-01008-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7853164/
https://www.ncbi.nlm.nih.gov/pubmed/33533012
http://dx.doi.org/10.1007/s13311-021-01008-7

Ejemplares similares